The zero‐sum game of pathway optimization: Emerging paradigms for tuning gene expression

With increasing price volatility and growing awareness of the lack of sustainability of traditional chemical synthesis, microbial chemical production has been tapped as a promising renewable alternative for the generation of diverse, stereospecific compounds. Nonetheless, many attempts to generate them are not yet economically viable. Due to the zero‐sum nature of microbial resources, traditional strategies of pathway optimization are attaining minimal returns. This result is in part a consequence of the gross changes in host physiology resulting from such efforts and underscores the need for more precise and subtle forms of gene modulation. In this review, we describe alternative strategies and emerging paradigms to address this problem and highlight potential solutions from the emerging field of synthetic biology.

[1]  F. Blattner,et al.  In silico design and adaptive evolution of Escherichia coli for production of lactic acid. , 2005, Biotechnology and bioengineering.

[2]  Hyung Joon Cha,et al.  Down‐regulation of acetate pathway through antisense strategy in Escherichia coli: Improved foreign protein production , 2003, Biotechnology and bioengineering.

[3]  C. Khosla,et al.  Engineered biosynthesis of novel polyketides: manipulation and analysis of an aromatic polyketide synthase with unproven catalytic specificities , 1993 .

[4]  D. Endy,et al.  Refinement and standardization of synthetic biological parts and devices , 2008, Nature Biotechnology.

[5]  Daniel C. Ducat,et al.  Insulation of a synthetic hydrogen metabolism circuit in bacteria , 2010, Journal of biological engineering.

[6]  C. Maranas,et al.  An optimization framework for identifying reaction activation/inhibition or elimination candidates for overproduction in microbial systems. , 2006, Metabolic engineering.

[7]  C. Kurland,et al.  Gratuitous overexpression of genes in Escherichia coli leads to growth inhibition and ribosome destruction , 1995, Journal of bacteriology.

[8]  L. Eggeling,et al.  Biology of L-lysine overproduction byCorynebacterium glutamicum , 1994, Amino Acids.

[9]  Jae-Gu Pan,et al.  Acetate Metabolism in a pta Mutant ofEscherichia coli W3110: Importance of Maintaining Acetyl Coenzyme A Flux for Growth and Survival , 1999, Journal of bacteriology.

[10]  J. Collins,et al.  Programmable cells: interfacing natural and engineered gene networks. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Costas D. Maranas,et al.  OptForce: An Optimization Procedure for Identifying All Genetic Manipulations Leading to Targeted Overproductions , 2010, PLoS Comput. Biol..

[12]  A. Goldberg,et al.  Production of abnormal proteins in E. coli stimulates transcription of ion and other heat shock genes , 1985, Cell.

[13]  J J Valdes,et al.  Quorum signaling via AI-2 communicates the "Metabolic Burden" associated with heterologous protein production in Escherichia coli. , 2001, Biotechnology and bioengineering.

[14]  Christopher A. Voigt,et al.  Automated Design of Synthetic Ribosome Binding Sites to Precisely Control Protein Expression , 2009, Nature Biotechnology.

[15]  Jens Nielsen,et al.  Production of plant sesquiterpenes in Saccharomyces cerevisiae: Effect of ERG9 repression on sesquiterpene biosynthesis , 2008, Biotechnology and bioengineering.

[16]  Timothy S. Ham,et al.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.

[17]  E. Papoutsakis,et al.  Aldehyde–alcohol dehydrogenase and/or thiolase overexpression coupled with CoA transferase downregulation lead to higher alcohol titers and selectivity in Clostridium acetobutylicum fermentations , 2009, Biotechnology and bioengineering.

[18]  D. F. Gibbs,et al.  The rise and fall (… and rise?) of acetone/butanol fermentations , 1983 .

[19]  J. Keasling,et al.  Engineering a mevalonate pathway in Escherichia coli for production of terpenoids , 2003, Nature Biotechnology.

[20]  Young Hwan Park,et al.  Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber , 2010, Proceedings of the National Academy of Sciences.

[21]  Christoph Wittmann,et al.  Metabolic Engineering of the Tricarboxylic Acid Cycle for Improved Lysine Production by Corynebacterium glutamicum , 2009, Applied and Environmental Microbiology.

[22]  Gabriel C. Wu,et al.  Synthetic protein scaffolds provide modular control over metabolic flux , 2009, Nature Biotechnology.

[23]  Kevin V. Solomon,et al.  Engineering microbes with synthetic biology frameworks. , 2008, Trends in biotechnology.

[24]  M. Pepsin,et al.  Application of metabolic engineering to improve both the production and use of biotech indigo , 2002, Journal of Industrial Microbiology and Biotechnology.

[25]  B A Pfeifer,et al.  Biosynthesis of Complex Polyketides in a Metabolically Engineered Strain of E. coli , 2001, Science.

[26]  W. R. Cluett,et al.  Dynamic metabolic engineering for increasing bioprocess productivity. , 2008, Metabolic engineering.

[27]  Keith E. J. Tyo,et al.  Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.

[28]  F. Arnold,et al.  Engineering microbial consortia: a new frontier in synthetic biology. , 2008, Trends in biotechnology.

[29]  B. Palsson,et al.  Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110 , 1994, Applied and environmental microbiology.

[30]  Robert T Sauer,et al.  Engineering controllable protein degradation. , 2006, Molecular cell.

[31]  E. W. Miles,et al.  The Molecular Basis of Substrate Channeling* , 1999, The Journal of Biological Chemistry.

[32]  S. Lee,et al.  Production of poly(3-hydroxybutyrate) by fed-batch culture of filamentation-suppressed recombinant Escherichia coli , 1997, Applied and environmental microbiology.

[33]  W. Bentley,et al.  Response dynamics of 26‐, 34‐, 39‐, 54‐, and 80‐kDa proteases in induced cultures of recombinant Escherichia coli , 1993, Biotechnology and Bioengineering.

[34]  E. Andrianantoandro,et al.  Synthetic biology: new engineering rules for an emerging discipline , 2006, Molecular systems biology.

[35]  S. Junne,et al.  Antisense RNA Downregulation of Coenzyme A Transferase Combined with Alcohol-Aldehyde Dehydrogenase Overexpression Leads to Predominantly Alcohologenic Clostridium acetobutylicum Fermentations , 2003, Journal of bacteriology.

[36]  J. Chin,et al.  Synthesis of orthogonal transcription-translation networks , 2009, Proceedings of the National Academy of Sciences.

[37]  Brian F. Pfleger,et al.  Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes , 2006, Nature Biotechnology.

[38]  P. R. Jensen,et al.  Synthetic promoter libraries--tuning of gene expression. , 2006, Trends in biotechnology.

[39]  O. Singh,et al.  Biotechnological production of gluconic acid: future implications , 2007, Applied Microbiology and Biotechnology.

[40]  B. Glick Metabolic load and heterologous gene expression. , 1995, Biotechnology advances.

[41]  Kristala L. J. Prather,et al.  Biosynthesis of chiral 3-hydroxyvalerate from single propionate-unrelated carbon sources in metabolically engineered E. coli , 2010, Microbial cell factories.

[42]  J. Rhee,et al.  Characterization and evaluation of a pta (phosphotransacetylase) negative mutant of Escherichia coli HB101 as production host of foreign lipase , 1994, Applied Microbiology and Biotechnology.

[43]  D. Jahn,et al.  Metabolic engineering of cobalamin (vitamin B12) production in Bacillus megaterium , 2009, Microbial biotechnology.

[44]  Jonathan A. Goler BioJADE: A Design and Simulation Tool for Synthetic Biological Systems , 2004 .

[45]  Sara Hooshangi,et al.  Autonomous induction of recombinant proteins by minimally rewiring native quorum sensing regulon of E. coli. , 2010, Metabolic engineering.

[46]  Christoph Wittmann,et al.  Systems level engineering of Corynebacterium glutamicum – Reprogramming translational efficiency for superior production , 2010 .

[47]  Chris J. Myers,et al.  Tablet—next generation sequence assembly visualization , 2009, Bioinform..

[48]  G. Bennett,et al.  Metabolic Engineering of Escherichia coli To Enhance Recombinant Protein Production through Acetate Reduction , 1995, Biotechnology progress.

[49]  Deepak Chandran,et al.  TinkerCell: modular CAD tool for synthetic biology , 2009, Journal of biological engineering.

[50]  M. Win,et al.  A modular and extensible RNA-based gene-regulatory platform for engineering cellular function , 2007, Proceedings of the National Academy of Sciences.

[51]  J. Glasner,et al.  Gene replacement without selection: regulated suppression of amber mutations in Escherichia coli. , 2003, Gene.

[52]  Christopher A. Voigt,et al.  Environmental signal integration by a modular AND gate , 2007, Molecular systems biology.

[53]  J. Neway,et al.  Improved expression of human interleukin-2 in high-cell-density fermentor cultures of Escherichia coli K-12 by a phosphotransacetylase mutant , 1990, Applied and environmental microbiology.

[54]  G. Gottschalk,et al.  Physiological Events in Clostridium acetobutylicum during the Shift from Acidogenesis to Solventogenesis in Continuous Culture and Presentation of a Model for Shift Induction , 1992, Applied and environmental microbiology.

[55]  W. R. Farmer,et al.  Improving lycopene production in Escherichia coli by engineering metabolic control , 2000, Nature Biotechnology.

[56]  J. Keasling,et al.  Low-copy plasmids can perform as well as or better than high-copy plasmids for metabolic engineering of bacteria. , 2000, Metabolic engineering.

[57]  Eva R. Kashket,et al.  Intracellular Conditions Required for Initiation of Solvent Production by Clostridium acetobutylicum , 1986, Applied and environmental microbiology.

[58]  A. Burgard,et al.  Optknock: A bilevel programming framework for identifying gene knockout strategies for microbial strain optimization , 2003, Biotechnology and bioengineering.

[59]  D. C. Cameron,et al.  Accumulation of methylglyoxal in anaerobically grown Escherichia coli and its detoxification by expression of the Pseudomonas putida glyoxalase I gene. , 2001, Metabolic engineering.

[60]  Chikara Furusawa,et al.  Effect of odhA overexpression and odhA antisense RNA expression on Tween-40-triggered glutamate production by Corynebacterium glutamicum , 2009, Applied Microbiology and Biotechnology.

[61]  Farren J. Isaacs,et al.  Tracking, tuning, and terminating microbial physiology using synthetic riboregulators , 2010, Proceedings of the National Academy of Sciences.

[62]  Joseph V. Kurian,et al.  A New Polymer Platform for the Future — Sorona® from Corn Derived 1,3-Propanediol , 2005 .

[63]  J. Keasling,et al.  Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production. , 2001, Biotechnology and bioengineering.

[64]  Richard Van Noorden Demand for malaria drug soars , 2010, Nature.

[65]  S. Carlsen,et al.  Production of recombinant human growth hormone in Escherichia coli: Expression of different precursors and physiological effects of glucose, acetate, and salts , 1990, Biotechnology and bioengineering.

[66]  D. Endy Foundations for engineering biology , 2005, Nature.

[67]  A. Ninfa,et al.  Role of phosphorylated metabolic intermediates in the regulation of glutamine synthetase synthesis in Escherichia coli , 1992, Journal of bacteriology.

[68]  B. Palsson,et al.  Metabolic Flux Balancing: Basic Concepts, Scientific and Practical Use , 1994, Bio/Technology.

[69]  Tae Seok Moon,et al.  Use of modular, synthetic scaffolds for improved production of glucaric acid in engineered E. coli. , 2010, Metabolic engineering.

[70]  G. Stephanopoulos,et al.  Tuning genetic control through promoter engineering. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Farren J. Isaacs,et al.  Engineered riboregulators enable post-transcriptional control of gene expression , 2004, Nature Biotechnology.

[72]  E. Papoutsakis,et al.  Design of Antisense RNA Constructs for Downregulation of the Acetone Formation Pathway of Clostridium acetobutylicum , 2003, Journal of bacteriology.

[73]  J. Ha,et al.  Allosteric switching by mutually exclusive folding of protein domains. , 2003, Journal of molecular biology.

[74]  R. Mahadevan,et al.  Estimating optimal profiles of genetic alterations using constraint-based models. , 2005, Biotechnology and bioengineering.

[75]  J. Collins,et al.  DIVERSITY-BASED, MODEL-GUIDED CONSTRUCTION OF SYNTHETIC GENE NETWORKS WITH PREDICTED FUNCTIONS , 2009, Nature Biotechnology.

[76]  A. Bories,et al.  3-Hydroxypropionaldehyde, an inhibitory metabolite of glycerol fermentation to 1,3-propanediol by enterobacterial species , 1996, Applied and environmental microbiology.

[77]  Eduardo Sontag,et al.  Modular cell biology: retroactivity and insulation , 2008, Molecular systems biology.

[78]  Jeremy Minshull,et al.  Engineering the Salmonella type III secretion system to export spider silk monomers , 2009, Molecular systems biology.

[79]  J Ovádi,et al.  Substrate channeling. , 1999, Methods.

[80]  Vassilios Sotiropoulos,et al.  SynBioSS: the synthetic biology modeling suite , 2008, Bioinform..

[81]  Mandy L. Wilson,et al.  GenoCAD for iGEM: a grammatical approach to the design of standard-compliant constructs , 2010, Nucleic acids research.

[82]  S. Hong,et al.  Biosynthesis of enantiopure (S)-3-hydroxybutyric acid in metabolically engineered Escherichia coli , 2008, Applied Microbiology and Biotechnology.

[83]  Jay D Keasling,et al.  Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. , 2007, Metabolic engineering.

[84]  M. Elowitz,et al.  Programming gene expression with combinatorial promoters , 2007, Molecular systems biology.

[85]  Jens Nielsen,et al.  Enhancement of farnesyl diphosphate pool as direct precursor of sesquiterpenes through metabolic engineering of the mevalonate pathway in Saccharomyces cerevisiae , 2010, Biotechnology and bioengineering.